Arrow International ACCESS TRAY kits recalled for compromised sterility of injectable drugs
Arrow International ACCESS TRAY recalled for sterility concerns
Arrow International's ACCESS TRAY kits (model ASK-04001-MC3) contain injectable anesthetic and saline solutions from a supplier with documented quality issues. If the sterility of these water-based injectables has been compromised, serious or life-threatening infections could result. The supplier also reported limited cases of drug ineffectiveness.
- Stop using affected ACCESS TRAY kits immediately if you have them.
- Check your inventory for model ASK-04001-MC3 and cross-reference against recalled lot numbers.
- Contact Arrow International or your supplier for instructions on return or safe disposal.
- Consult your healthcare facility's pharmacy or compliance officer for next steps.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2392-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief